Human Genome Epidemiology Literature Finder
Records 1 - 2 (of 2 Records) |
Query Trace: Psoriasis and CYP2C19[original query] |
---|
Allelic variants of drug metabolizing enzymes as risk factors in psoriasis. The Journal of investigative dermatology 2003 May 120 (5): 765-70. Richter-Hintz Dagmar, Their Ricarda, Steinwachs Swantje, Kronenberg Sven, Fritsche Ellen, Sachs Bernd, Wulferink Marty, Tonn Torsten, Esser Charlot |
Investigation of the influence of CYP1A2 and CYP2C19 genetic polymorphism on 2-Cyano-3-hydroxy-N-[4-(trifluoromethyl)phenyl]-2-butenamide (A77 1726) pharmacokinetics in leflunomide-treated patients with rheumatoid arthritis. Drug metabolism and disposition: the biological fate of chemicals 2009 Oct 37 (10): 2061-8. Bohanec Grabar Petra, Grabnar Iztok, Rozman Blaz, Logar Dusan, Tomsic Matija, Suput Dasa, Trdan Tina, Peterlin Masic Lucija, Mrhar Ales, Dolzan Vi |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: